This campaign has been commissioned by an international Japanese pharmaceutical company who combat diseases with a combination of ground‑breaking technology and biology, with an extensive track record of academic collaboration. They are seeking a solution that achieves neuron regeneration or axon regeneration within glial scarring in animal models.
Regeneration within glial scarring caused by the following diseases are of interest to the client:
- Stroke
- Spinal cord injury
- Traumatic brain injury
- Parkinson’s disease
- Charcot-Marie-Tooth disease
- Huntington disease...